Home

Indo Us Bio-tech Ltd Quarterly Result

Image

Indo US Bio-Tech Ltd

NSE: INDOUS

Net Profit - Last Quarter

₹ 4.36 Cr.

Last updated on: Jan 15, 2025

Key Highlights

  • The revenue of Indo US Bio-Tech Ltd for the Sep '24 is ₹ 22.19 crore as compare to the Jun '24 revenue of ₹ 24.75 crore. This represent the decline of -10.343431%.
  • The ebitda of Indo US Bio-Tech Ltd for the Sep '24 is ₹ 5.14 crore as compare to the Jun '24 ebitda of ₹ 3.72 crore. This represent the growth of 38.17204%.
  • The net profit of Indo US Bio-Tech Ltd for the Sep '24 is ₹ 4.36 crore as compare to the Jun '24 net profit of ₹ 3.17 crore. This represent the growth of 37.539433%.

Results Analysis

Market Price of Indo US Bio-Tech Ltd

1M

1Y

3Y

5Y

Monitoring Indo US Bio-Tech Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
15 Jan 2025234.35
14 Jan 2025228.65
13 Jan 2025236
10 Jan 2025245.35
09 Jan 2025256
08 Jan 2025267.95
07 Jan 2025268.8
06 Jan 2025273.65
03 Jan 2025287.75
02 Jan 2025287

Historical Revenue of Indo US Bio-Tech Ltd

No data available

* All values are in crore

Historical EBITDA of Indo US Bio-Tech Ltd

No data available

* All values are in crore

Historical Net Profit of Indo US Bio-Tech Ltd

No data available

* All values are in crore

Indo US Bio-Tech Ltd News Hub

Indo US Bio-Tech standalone net profit rises 33.76% in the June 2024 quarter

Net profit of Indo US Bio-Tech rose 33.76% to Rs 3.17 crore in the quarter ended June 2024 as agains

Read more

09 Aug 2024

Indo US Bio-Tech to announce Quarterly Result

Indo US Bio-Tech will hold a meeting of the Board of Directors of the Company on 8 August 2024. Powe

Read more

02 Aug 2024

Indo US Bio-Tech to conduct AGM

Indo US Bio-Tech announced that the Annual General Meeting (AGM) of the company will be held on 30 S

Read more

18 Sep 2024

Indo US Bio-Tech announces board meeting date

Indo US Bio-Tech will hold a meeting of the Board of Directors of the Company on 14 November 2024 Po

Read more

07 Nov 2024

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Quarterly Results of Indo US Bio-Tech Ltd

What key financial metrics are included in Indo US Bio-Tech Ltd's quarterly results?

Key financial metrics in Indo US Bio-Tech Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Indo US Bio-Tech Ltd announce its quarterly results?

Indo US Bio-Tech Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Indo US Bio-Tech Ltd's quarterly performance impact its stock price?

Indo US Bio-Tech Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Indo US Bio-Tech Ltd's quarterly results on dividends?

The impact of Indo US Bio-Tech Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Indo US Bio-Tech Ltd's quarterly results?

Yes, Indo US Bio-Tech Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions